Status:
COMPLETED
High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease
Lead Sponsor:
NYU Langone Health
Conditions:
Parkinson Disease
Eligibility:
All Genders
Up to 100 years
Phase:
NA
Brief Summary
The overall goal of this T2 translational research project is to pilot an interdisciplinary high-intensity group singing program to improve speech and swallowing in patients with Parkinson's Disease (...
Detailed Description
Deterioration of speech and swallowing is a hallmark of Parkinson Disease (PD). There is emerging evidence that choral singing benefits people with PD across a range of modalities. Despite the increas...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of Stage One, Two or Three on the Hoehn and Yahr Staging of Parkinson's Disease
- Current swallowing severity of normal, mild, or moderate without aspiration
- Stable regimen of anti-PD medication for \>30 days
Exclusion
- Prior voice and/or swallowing therapy related to PD
- History of head and neck cancer
- History of oropharyngeal or laryngeal surgery
- Current or former smoker (quit \< 5 years)
Key Trial Info
Start Date :
August 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 13 2017
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03263793
Start Date
August 22 2017
End Date
December 13 2017
Last Update
August 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016